The rich influx of CD8+ T cells, PD-L1 expression, and activated IFN signaling in TNBC patient tumors with high LMP7 expression prompted us to investigate the effects of M3258 on the immune landscape of TNBC/IBC. The gene discussed is IFNA1; the disease is inflammatory breast carcinoma.